Michael J. Garle

888 total citations
27 papers, 736 citations indexed

About

Michael J. Garle is a scholar working on Pharmacology, Biochemistry and Small Animals. According to data from OpenAlex, Michael J. Garle has authored 27 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Biochemistry and 7 papers in Small Animals. Recurrent topics in Michael J. Garle's work include Pharmacogenetics and Drug Metabolism (10 papers), Animal testing and alternatives (7 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Michael J. Garle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Animal testing and alternatives (7 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). Michael J. Garle collaborates with scholars based in United Kingdom, Sweden and Italy. Michael J. Garle's co-authors include Jeffrey R. Fry, Victoria Chapman, David A. Barrett, David A. Kendall, Richard G. Pearson, Denise Richardson, Brigitte E. Scammell, Alison H. Hammond, Alison J. Reeve and M.L. Latif and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Neuropharmacology.

In The Last Decade

Michael J. Garle

26 papers receiving 708 citations

Peers

Michael J. Garle
M.J. Garle United Kingdom
Koji Ueshima Japan
Sachiko Kanai Japan
Aimée Dallob United States
Yun‐Beom Sim South Korea
Tuncay Altuğ Türkiye
R. Ceserani Italy
Helena Pontes Portugal
Shi‐Xun Ma South Korea
Chang Yell Shin South Korea
M.J. Garle United Kingdom
Michael J. Garle
Citations per year, relative to Michael J. Garle Michael J. Garle (= 1×) peers M.J. Garle

Countries citing papers authored by Michael J. Garle

Since Specialization
Citations

This map shows the geographic impact of Michael J. Garle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Garle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Garle more than expected).

Fields of papers citing papers by Michael J. Garle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Garle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Garle. The network helps show where Michael J. Garle may publish in the future.

Co-authorship network of co-authors of Michael J. Garle

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Garle. A scholar is included among the top collaborators of Michael J. Garle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Garle. Michael J. Garle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garle, Michael J., et al.. (2025). Effect of 3‐mercaptopyruvate sulfurtransferase (3‐MST) inhibitors on contractile responses in porcine coronary artery. British Journal of Pharmacology. 182(22). 5453–5468.
2.
Harper, Andrew R., et al.. (2023). GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid. Vascular Pharmacology. 152. 107199–107199. 3 indexed citations
3.
Garle, Michael J., Stephen G. John, Susan Anderson, et al.. (2013). P16 Plasma hydrogen sulfide (H2S) levels in CKD patients. Nitric Oxide. 31. S41–S41. 2 indexed citations
4.
Garle, Michael J., et al.. (2013). P11 Hydrogen sulfide and its effect on the hypoxic response in porcine coronary arteries. Nitric Oxide. 31. S38–S39. 3 indexed citations
5.
Sagar, Devi Rani, Bright N. Okine, Stephen G. Woodhams, et al.. (2010). Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis & Rheumatism. 62(12). 3666–3676. 102 indexed citations
6.
7.
Richardson, Denise, Richard G. Pearson, Nisha Kurian, et al.. (2008). Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Research & Therapy. 10(2). R43–R43. 250 indexed citations
8.
Garle, Michael J., et al.. (2000). Stimulation of dichlorofluorescin oxidation by capsaicin and analogues in RAW 264 monocyte/macrophages: lack of involvement of the vanilloid receptor. Biochemical Pharmacology. 59(5). 563–572. 33 indexed citations
9.
Hammond, Alison H., Michael J. Garle, & Jeffrey R. Fry. (1999). The Nature of Halogen Substitution Determines the Mode of Cytotoxicity of Halopropanols. Toxicology and Applied Pharmacology. 155(3). 287–291. 10 indexed citations
10.
Clothier, Richard, et al.. (1999). The Use of Human Keratinocytes in the EU/COLIPA International In Vitro Phototoxicity Test Validation Study and the ECVAM/COLIPA Study on UV Filter Chemicals. Alternatives to Laboratory Animals. 27(2). 247–259. 21 indexed citations
11.
Hammond, Alison H., Michael J. Garle, & Jeffrey R. Fry. (1996). Toxicity of dichloropropanols in rat hepatocyte cultues. Environmental Toxicology and Pharmacology. 1(1). 39–43. 28 indexed citations
12.
Garle, Michael J., et al.. (1996). 7−Ethoxy−3,4−dimethylcoumarin: A Substrate for a Cytochrome p450-mediated Mono-oxygenase Activity that is Highly Induced by Phenobarbitone and β-Naphthoflavone. Journal of Pharmacy and Pharmacology. 48(7). 729–733. 2 indexed citations
13.
Garle, Michael J. & Jeffrey R. Fry. (1996). A Comparison of Hepatic Enzyme Activities and their Modulation by Dexamethazone in Freshly Isolated and Cultured Hepatocytes and in the Differentiated Hepatoma Cell Line, 2sFou. Alternatives to Laboratory Animals. 24(1). 31–37. 1 indexed citations
14.
Seibert, Hasso, Michael Balls, Julia H. Fentem, et al.. (1996). Acute Toxicity Testing in Vitro and the Classification and Labelling of Chemicals. Alternatives to Laboratory Animals. 24(4). 499–510. 32 indexed citations
15.
Hammond, Alison H., Michael J. Garle, & Jeffrey R. Fry. (1995). Mechanism of toxicity of precocene II in rat hepatocyte cultures. Journal of Biochemical Toxicology. 10(5). 265–273. 17 indexed citations
16.
17.
Dominguez, Karen, Julia H. Fentem, Michael J. Garle, & Jeffrey R. Fry. (1990). Comparison of Mongolian gerbil and rat hepatic microsomal monooxygenase activities: High coumarin 7-hydroxylase activity in the gerbil. Biochemical Pharmacology. 39(10). 1629–1631. 12 indexed citations
18.
Garle, Michael J. & Jeffrey R. Fry. (1989). Detection of reactive metabolites in vitro. Toxicology. 54(1). 101–110. 42 indexed citations
19.
Fry, Jeffrey R., Michael J. Garle, & Alison H. Hammond. (1988). The Detection of Reactive Metabolites Generated by the Microsomal Mixed Function Oxidase System. Alternatives to Laboratory Animals. 16(1). 8–13. 1 indexed citations
20.
Garle, Michael J., Alison H. Hammond, & Jeffrey R. Fry. (1987). The Cytotoxicity of 27 Chemicals to V79 Chinese Hamster Cells. Alternatives to Laboratory Animals. 15(1). 30–32. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.J. Garle Breakdown of academic impact, for papers by Koji Ueshima Breakdown of academic impact, for papers by Sachiko Kanai Breakdown of academic impact, for papers by Aimée Dallob Breakdown of academic impact, for papers by Yun‐Beom Sim Breakdown of academic impact, for papers by Tuncay Altuğ Breakdown of academic impact, for papers by R. Ceserani Breakdown of academic impact, for papers by Helena Pontes Breakdown of academic impact, for papers by Shi‐Xun Ma Breakdown of academic impact, for papers by Chang Yell Shin
Rankless by CCL
2026